The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
Private equityAmsterdam, The Netherlandscatalyze-capital.comSince 2026-09-29
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Breye Therapeutics A clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases | Series A Verified against 4 of 11 sources | $75.8M | 2026-09-29 | [ PART ] |